LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Andrew Pettitt"
  2. AU="Malawski, M"
  3. AU=Marhofer P
  4. AU=Mandel H G
  5. AU="Duffy, Richard"
  6. AU=Kaseb Hatem AU=Kaseb Hatem
  7. AU=Kong Tak?kwan AU=Kong Tak?kwan
  8. AU=Nagaraja Sridevi
  9. AU="Bu, Yingzi"
  10. AU=Seddighi Hamed AU=Seddighi Hamed
  11. AU="De Keyser, Johan"
  12. AU="Zhenqiang Bi"
  13. AU=Wang Jun
  14. AU=Zhang Fuping
  15. AU="Shatilov, D N"

Suchergebnis

Treffer 1 - 2 von insgesamt 2

Suchoptionen

  1. Artikel ; Online: An increased fraction of circulating miR-363 and miR-16 is particle bound in patients with chronic lymphocytic leukaemia as compared to normal subjects

    Afaf Alharthi / Daniel Beck / Dena R. Howard / Peter Hillmen / Melanie Oates / Andrew Pettitt / Simon D. Wagner

    BMC Research Notes, Vol 11, Iss 1, Pp 1-

    2018  Band 7

    Abstract: Abstract Objectives In vitro culture studies have shown that miR-363 is enriched in extracellular vesicles from chronic lymphocytic leukaemia cells. We wondered whether miR-363 was detectable in plasma, which is an essential precondition for further ... ...

    Abstract Abstract Objectives In vitro culture studies have shown that miR-363 is enriched in extracellular vesicles from chronic lymphocytic leukaemia cells. We wondered whether miR-363 was detectable in plasma, which is an essential precondition for further studies to assess its usefulness as a biomarker. Using samples from two clinical trials: one enrolling patients with advanced disease and the other asymptomatic patients with early stage disease, we determined plasma miR-363 levels and secondly investigated the distribution of this miRNA between plasma and particle bound fractions in patients and normal subjects. Results Advanced disease (n = 95) was associated with higher levels of miR-363 than early stage disease (n = 45) or normal subjects (n = 11) but there was no association with markers of prognosis. The distribution of specific miRNA between particle bound and plasma protein fractions was investigated using size exclusion chromatography on plasma from patients (n = 4) and normal subjects (n = 3). ~ 20% of total miR-16 and miR-363 is particle bound in patients while there was no detectable particle bound material in normal subjects. Our work demonstrates that miR-363 levels are raised in chronic lymphocytic leukaemia patients and raises the possibility that distribution of circulating miRNA between plasma fractions differs in health and disease.
    Schlagwörter Chronic lymphocytic leukaemia ; miRNA ; Extracellular vesicle ; Medicine ; R ; Biology (General) ; QH301-705.5 ; Science (General) ; Q1-390
    Thema/Rubrik (Code) 610
    Sprache Englisch
    Erscheinungsdatum 2018-05-01T00:00:00Z
    Verlag BMC
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia

    Wei-Yu Lin / Sarah E. Fordham / Nicola Sunter / Claire Elstob / Thahira Rahman / Elaine Willmore / Colin Shepherd / Gordon Strathdee / Tryfonia Mainou-Fowler / Rachel Piddock / Hannah Mearns / Timothy Barrow / Richard S. Houlston / Helen Marr / Jonathan Wallis / Geoffrey Summerfield / Scott Marshall / Andrew Pettitt / Christopher Pepper /
    Christopher Fegan / Francesco Forconi / Martin J. S. Dyer / Sandrine Jayne / April Sellors / Anna Schuh / Pauline Robbe / David Oscier / James Bailey / Syed Rais / Alison Bentley / Lynn Cawkwell / Paul Evans / Peter Hillmen / Guy Pratt / David J. Allsup / James M. Allan

    Nature Communications, Vol 12, Iss 1, Pp 1-

    2021  Band 8

    Abstract: The clinical course of chronic lymphocytic leukaemia (CLL) is variable and difficult to predict. Here, the authors conduct a genome wide association study meta-analysis for time to first treatment in CLL patients and report two loci associating with ... ...

    Abstract The clinical course of chronic lymphocytic leukaemia (CLL) is variable and difficult to predict. Here, the authors conduct a genome wide association study meta-analysis for time to first treatment in CLL patients and report two loci associating with progressive disease.
    Schlagwörter Science ; Q
    Sprache Englisch
    Erscheinungsdatum 2021-01-01T00:00:00Z
    Verlag Nature Portfolio
    Dokumenttyp Artikel ; Online
    Datenquelle BASE - Bielefeld Academic Search Engine (Lebenswissenschaftliche Auswahl)

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang